XWe have detected your location as outside the U.S/Canada, if you think this is wrong, you can choose your location.

Macmillan Higher Education Celebrating 20 years of Macmillan Study Skills

Cart

Continue Shopping
All prices are shown excluding Tax
The submitted promocode is invalid
Discount code already used. It can only be used once.
* Applied promocode: ×

Important information on your ebook order

Good Pharma Offer

Good Pharma
BUY this book

Donald W. Light, Antonio F. Maturo
July 2015 | Hardback | 9781137388339
288 pages

£42.00 rrp £59.50 $66.50 rrp $95.00

Palgrave Macmillan is delighted to be able to offer a 30% discount* on Donald W. Light and Antonio F. Maturo's new book Good Pharma:The Public-Health Model of the Mario Negri Institute. Order your copy now at the special price of just £42.00/$66.50 (rrp £59.50/$95.00) by entering the discount code PM15THIRTY at the check out. Valid until 30th November 2015.

Instructions: Click the 'Buy this Book' button below, then 'Add to Basket'. Once you have done this, simply click on the 'Basket' link at the top of the page, where you will be able to enter the above code to receive your discount.

*Terms and conditions can be found here.











Reviews

...combines a devastating critique of the pervasive harms of patent-driven medical research by the pharmaceutical industry with a compelling account of an alternative...'-Eric Olin Wright, Vilas Distinguished Professor, University of Wisconsin, Past-President American Sociological Association
... a bright light on a remarkable approach to conducting pharmacological research in the public interest... research motivated by... a social mission centered on compassion for and responsibility to the vulnerable, sick and suffering.' -Arthur L Caplan, Mitty Professor of Bioethics, New York University

Description

Good Pharma describes a working model of institutional integrity that bypasses the many ways that commercialized research has corrupted transparent science, valid results, and trustworthy clinical practice. It is the answer to Goldacre's book, Bad Pharma: ethical research without commercial distortions that mislead doctors and patients.

On the basis of key concepts in sociology and management, the authors describe the history of a remarkable institute that has elevated medical research and worked out solutions to the troubling practices of commercial pharmaceutical research. This extended case history of the Mario Negri Institute describes how a brilliant young researcher, Silvio Garattini, and a boldly imaginative philanthropist, Mario Negri, conceived of an independent, ethics-based research institute to develop better medicines for patients rather than medicines better for patenting.

Drawing on its public health model, the Institute developed the first methods for founding the WHO Essential Medicines List, as well as regional and national formularies of effective, safe drugs. It was an early partner with the Cochrane Collaboration, and it campaigned to reduce secrecy and commercial influences on how drugs are approved.

The public health model of the Mario Negri Institute offers a breakthrough, already-successful way to develop better drugs at much lower prices than today's costly, wasteful drug, with few benefits for patients. An important book to provoke discussion in global public health, science and technology, history, and ethics courses.


Contents

1. List of Illustrations
2. Foreword
3. Preface and Acknowledgements
4. List of Abbreviations
5. Introduction: Beneficence through Principled Research for Patients
PART I: DEVELOPING A RESEARCH INSTITUTE FOR SOCIETY
6. Origins and American Inspirations
7. The Formative Years –Leadership, Culture & Organization
8. Expansions to New Campuses and Integrated Research
9. Educating the Public and Future Researchers
PART II: RECONCEIVING THE AIMS OF PHARMACOLOGICAL RESEARCH
10. From Measuring Environmental Toxins to Drugs as Contaminants
11. Pioneering Ethical Trials for Integrated Research
PART III: PROMOTING GOOD SCIENCE FOR BETTER MEDICINES
12. Science-based Initiatives Against Dangerous or Useless Drugs
13. Global Campaigns Against Harmful Regulations and Practices
14. Good Science for Good Pharma – A Global Model
15. Appendices

About the Authors

Donald W. Light is Professor of Comparative Health Policy at Rowan University, USA and has published widely in major medical and sociological journals on ethical as well as sociological issues. Recently, he served as the Lokey Visiting Professor at Stanford University, USA and as a Visiting Fellow at Harvard University, USA.

Antonio Maturo is Associate Professor of Sociology of Health at Bologna University, Italy and Visiting Professor at Brown University, USA. He has published several books in Italian and he has edited The Medicalization of Life (2009, with P. Conrad) and The Medicine of Emotions and Cognitions (2012, with K. Barker).